CME/CE Accreditation Information Return to Previous

Title

Caring for Patients with Atopic Dermatitis: Incorporating Pathophysiology into a Comprehensive Management Plan

Primary Topic

Atopic Dermatitis

Primary Audience:

Dermatologists, Pediatric Dermatologists, Nurse Practitioners, Physician Assistants, Primary Care Physicians, Pediatricians

Launch date

1/30/21

Expiration Date

1/29/22

Program Overview

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense itching and recurrent eczematous lesions. The disease affects up to 20% of children and up to 3% of adults. AD usually starts in childhood, and may represent the cutaneous manifestation of an “atopic march” in which most patients also develop asthma and allergic rhinitis.

AD has a tremendous negative impact on the quality of life of both patients and their families. The disease is associated with several comorbidities, including mental health disorders (depression, anxiety, autism, ADHD), hypertension, obesity, infections, osteoporosis, fractures, vitiligo, alopecia areata, visual problems, and dental issues. Patients are more accident-prone Sleep disturbances are common, and persist even during periods of remission.

This online course will examine the clinical characteristics, the current immuno-pathophysiology, and the psychosocial and quality of life impact of AD on patients across age groups, and provide strategies to individualize treatment for patients with atopic dermatitis. 

The course includes self-assessment modules, case-based modules, group tasks and live group discussions. 

Learning Objectives

  1. Discuss the role of Th2 inflammation in the pathogenesis of atopic dermatitis (AD), and implications for management of these conditions.
  2. Identify and appropriately manage comorbidities associated with AD to improve their impact on quality of life.
  3. Implement effective strategies for comprehensively managing AD in children and adults.

Course Directors
Brad P. Glick, DO, MPH, FAAD, FAOCD
Program Director, Dermatology Residency
Larkin Community Hospital Palm Springs
Deputy Chair, Individual Giving Committee, AAD
Vice President, Florida Society for Dermatology and Dermatologic Surgery
Clinical Assistant Professor of Dermatology
Herbert Wertheim College of Medicine
Miami, FL

Elizabeth (Lisa) Swanson, MD
Ada West Dermatology
St Luke’s Children’s Hospital
Boise, ID

Provider

The National Association for Continuing Education

 

ACCME Accreditation Statement

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The National Association for Continuing Education designates this other (blended live and enduring curriculum) activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP Accreditation Statement

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 2.75 contact hour(s) (which includes 0.50 hour(s) of pharmacology).

How to claim credit

  1.  Review the course front matter.
  2.  Participate in the course.
  3. Once your group completes all modules of the course, you will receive a notification with a link to complete the post-test, activity evaluation and claim your CE credit.
  4. You must score 70% or higher on the post-test to claim credit for this activity.
  5. Claim total credit commensurate with your participation in the activity as follows:

 

  • Module 1: Caring for Patients with Atopic Dermatitis: Incorporating Pathophysiology into a Comprehensive Management Plan – Baseline Self-Assessment
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 AANP contact hour(s) (which includes 0.25 hour(s) of pharmacology)
  • Module 2: Self Study - Dan: Optimizing Care for Atopic Dermatitis
  • 0.25 AMA PRA Category 1 Credits
  • 0.25 AANP contact hour(s)
  • Module 3: Self Study - Lynne: Recognizing Inflammation and Comorbidities Associated with AD
  • 0.25 AMA PRA Category 1 Credits
  • 0.25 AANP contact hour(s)
  • Module 4: Caring for Patients with Atopic Dermatitis: Incorporating Pathophysiology into a Comprehensive Management Plan - Final Self-Assessment
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 AANP contact hour(s) (which includes 0.25 hour(s) of pharmacology)
  • Module 5: Live Group Discussion 1
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 AANP contact hour(s)
  • Module 6: Live Group Discussion 2
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 AANP contact hour(s)
  • Module 7: Group Task
  • 0.25 AMA PRA Category 1 Credits
  • 0.25 AANP contact hour(s)

Policy on Faculty and Provider Disclosure

Educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Any potential conflicts of interest will be resolved prior to the activity.

Per the ACCME, a Commercial Interest is defined as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on, patients. Providers of clinical service directly to patients are not considered to be commercial interests - unless the provider of the clinical service is owned, or controlled by, a defined commercial interest.

Faculty Disclosures

Brad Glick, DO has disclosed the following financial relationships:

Investigator: AbbVie, Celgene, ChemoCentryx, Dermira, and Sun Pharma.

Advisory Board Member: AbbVie, Celgene, Dermavant, Dermira, Genzyme, Lilly Novartis, Ortho Dermatologics, Pfizer, Sanofi, and Sun Pharma.

Speaker/Teaching: AbbVie, Celgene, Dermira, Lilly, Ortho Dermatologics, Novartis, Pfizer, and Sun Pharma.

All relevant financial relationships have been mitigated.

 

Elizabeth (Lisa) Swanson, MD has disclosed the following financial relationships:

Advisory Board Member: Sanofi Regeneron, Janssen, Lilly, Ortho Dermatologics, Cassiopea

Speakers Bureau: Ortho Dermatologics, Pfizer, Amgen, Sanofi Regeneron, Almirall, Janssen, Lilly

Speaking/Teaching: Ortho Dermatologics, Pfizer, Amgen, Sanofi Regeneron, Almirall, Janssen, Lilly

All relevant financial relationships have been mitigated.

Planning Committee Disclosures

Gregg Sherman, MD, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Laurl Ann Matey, MSN, RN, CHPN, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Angela Golden, DNP, FNP-C, FAANP, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Michelle Frisch, MPH, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Sheila Lucas, CWEP, Activity Planning Committee, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Joshua Kilbridge, Medical Writer, has no relevant conflicts of interest with any ACCME-defined commercial interest.

Disclosure of Commercial Support

This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Disclosure of Unlabeled/Investigational Uses of Products

The content of the presentations may include discussion of unapproved or investigational uses of product or devices.

Course format/medium: Internet CME Activity

Estimated time to complete the activity: 2 hours and 45 minutes

Supported Browsers:

Internet Explorer 8.0+ for Windows 2000, 2003,

Vista, XP, Windows 7, Windows 8, and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.

Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above